RECCE PHARMACEUTICALS LTD has not announced any capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
18 October 2017
7 October 2019
6 February 2019
Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of antibiotics. RCE's portfolio of antibiotic therapies seek to address health threats posed by drug resistant bacteria. Their lead candidate RECCE®327 is designed as abroad-spectrum antibiotic, formulated using synthetic polymer technology to treat bacterial sepsis (blood poisoning) and other bacterial infections, including superbugs.
Level 36, Gateway, 1 Macquarie Pl, Sydney NSW 2000, Australia
Fresh Equities does not have RECCE PHARMACEUTICALS LTD quarterly cash flows data.
Fresh Equities does not have RECCE PHARMACEUTICALS LTD directors data.
Fresh Equities does not have RECCE PHARMACEUTICALS LTD announcements data.
Fresh Equities does not have RECCE PHARMACEUTICALS LTD news data.